Intas Pharma and Comera Life Sciences enter into a research partnership

Intas Pharmaceuticals announced a research collaboration with Comera Life Sciences to develop a new generation of bio-innovative biologic medicines.

Under the terms of the partnership agreement, Comera will develop a differentiated formulation of an Intas product using Comera’s innovative proprietary SQore formulation platform. Intas will initially provide research funding with the option to acquire global rights to the formulation through an exclusive license with responsibility for subsequent development and commercialisation.